Researchers find predictors of worse MS outcomes in post hoc study of three trialsFebruary 28, 2018Multiple Sclerosis
Fingolimod switch from an injectable linked to improved outcomes in relapsing MSFebruary 26, 2018Multiple Sclerosis
Extended-interval dosing of natalizumab linked to lower risk of PMLFebruary 22, 2018Multiple Sclerosis
Do Neurologists Adequately Screen Patients With MS for Cognitive Impairment and Depression?February 14, 2018Multiple Sclerosis
Study identifies characteristics that may constitute the MS prodromeFebruary 11, 2018Multiple Sclerosis
VIDEO: Teriflunomide and dimethyl fumarate are comparable in relapsing-remitting MSFebruary 9, 2018Multiple Sclerosis
‘Real-world evidence’ used to compare agents for relapsing-remitting MSFebruary 7, 2018Multiple Sclerosis
